BioCentury
ARTICLE | Financial News

Athyrium, Neuberger close $2B third fund

December 2, 2017 12:11 AM UTC

Athyrium Capital Management and Neuberger Berman closed Athyrium Opportunities Fund III at $2.025 billion.

The new fund will make investments in commercial-stage companies across the healthcare ecosystem, with more than 50% of the capital expected to be allocated to biopharma companies...